Viridian Therapeutics, Inc. Common Stock

Viridian Therapeutics, Inc. Common Stock (VRDN) trades at $18.24 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, VRDN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Oct 5, 2026.